CLINICAL_TRIALS
trial_result
· 2024-06-20
Clinical Trial Update: Efficacy and Safety of SYNB1934 in Patients With PKU (SYNPHENY-3) [Phase 3]
Summary
Phase 3 trial SYNPHENY-3 evaluating SYNB1934 in phenylketonuria was terminated. Results were posted in June 2024.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Synlogic | Conditions: Phenylketonuria | Phase 3 | Status: TERMINATED | Results posted: 2024-06-20